The neuroprotective effect of deferoxamine in the hypoxic-ischemic immature mouse brain

Neuroscience Letters

Volumn 282, Issue 1-2, 2000, Pages 113-116

  Sarco, Dean P ^a   Becker, Joseph ^a   Palmer, Charles ^b   Sheldon, R Ann ^a   Ferriero, Donna M ^a  

^a Neonatal Brain Disorders Center   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Deferoxamine; Fenton reaction; Hypoxia ischemia; Iron; Neonatal; Superoxide dismutase

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; DEFEROXAMINE; DEFEROXAMINE MESYLATE; IRON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; GENE OVEREXPRESSION; HISTOPATHOLOGY; HYPOXIA; IRON CHELATION; MOUSE; NEUROPROTECTION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; ANIMALS, NEWBORN; BRAIN; DEFEROXAMINE; HISTOLOGICAL TECHNIQUES; HYPOXIA-ISCHEMIA, BRAIN; MICE; MICE, TRANSGENIC; NEUROPROTECTIVE AGENTS; SUPEROXIDE DISMUTASE;

EID: 0034677852     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(00)00878-8     Document Type: Article

References (18)

1. Coyle J.T., Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science. 262:1993;689-694.
2. Crowe A., Morgan E.H. Effects of chelators on iron uptake and release by the brain in the rat. Neurochem. Res. 19:(1):1994;71-76.
3. D'Souza S.W., Slater P. Excitatory amino acids in the neonatal brain: contributions to pathology and therapeutic strategies. Arch. Dis. Child. 72:(3):1995;F147-F150.
4. Ditelberg J.S., Sheldon R.A., Epstein C.J., Ferriero D.M. Brain injury after perinatal hypoxia-ischemia is exacerbated in Cu/Zn SOD transgenic mice. Pediatr. Res. 39:1996;204-208.
5. Dwork A.J., Lawler G., Zybert P.A., Durkin M., Osman M., Willson N., Barkai A.I. An autoradiographic study of the uptake and distribution of iron by the brain of the young rat. Brain. Res. 518:(1/2):1990;31-39.
6. Epstein C.J., Avraham K.B., Lovett M., Smith S., Elroy-Stein O., Rotman G., Bry C., Grooner Y. Transgenic mice with increased Cu/Zn superoxide dismutase activity: animal model of dosage effects in Down syndrome. Proc. Natl. Acad. Sci. USA. 84:1987;8044-8048.
7. Fullerton H.J., Ditelberg J.S., Chen S.F., Sarco D.P., Chan P.K., Epstein C.J., Ferriero D.M. Copper/zinc superoxide dismutase transgenic brain accumulates hydrogen peroxide after perinatal hypoxia ischemia. Ann. Neurol. 44:(3):1998;357-364.
8. Gutteridge J.M.C., Richmond R., Halliwell B. Inhibition of iron-catalyzed formation of hydroxyl radicals from superoxide and of lipid peroxidation by desferrioxamine. Biochem. J. 184:1979;469-472.
9. Halliwell B. Protection against tissue damage in vivo by desferrioxamine: What is its mechanism of action? Free Radical Biol. Med. 7:1989;645-651.
10. Kinouchi H., Epstein C.J., Mizui T., Carlson E., Chen S.F., Chan P.H. Attenuation of focal cerebral ischemic injury in transgenic mice overexpressing Cu/Zn SOD. Proc. Natl. Acad. Sci. USA. 88:1991;11158-11162.
11. Mischel R.E., Young S.K., Sheldon R.A., Ferriero D.M. Hydrogen peroxide is selectively toxic to immature murine neurons in vitro. Neurosci. Lett. 231:1997;17-20.
12. Palmer C., Roberts R.L., Bero C. Deferoxamine posttreatment reduces ischemic brain injury in neonatal rats. Stroke. 25:(5):1994;1039-1045.
13. Palmer C. Hypoxic-ischemic encephalopathy: therapeutic approaches against microvascular injury and the role of neutrophils, PAF, and free radicals. Clin. Perinatal. 22:1995;481-517.
14. Palmer C., Menzies S.L., Roberts R.L., Pavlic G., Connor J.R. Changes in iron histochemistry after hypoxic-ischemic injury in the neonatal rat. J. Neurosci. Res. 56:1999;60-71.
15. Rice J.E., Vannucci R.C., Brierly J.B. The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann. Neurol. 9:1981;131-141.
16. Shimoni E., Armon R., Neeman I. Antioxidant properties of deferoxamine. J. Am. Oil. Chem. Soc. 71:1994;641-644.
17. Taylor E.M., Morgan E.H. Developmental changes in transferrin and iron uptake by the brain in the rat. Dev. Brain. Res. 55:1990;43-50.
18. Wang G.L., Jiang B-H., Rue E.A., Semenza G.L. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular oxygen tension. Proc. Natl. Acad. Sci. USA. 92:1995;5510-5514.